Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
The Department of Orthopaedic Surgery at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medi...
Researchers from the National Institute of Education, Nanyang Technological University, Singapore (NIE NTU, Singapore)...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an arti...
This year’s meeting highlighted a dramatic shift in the geography of cancer drug development. Long viewed as &ldqu...
A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Si...
As Asia’s biologics ecosystem continues to scale rapidly across monoclonal antibodies, biosimilars, and ad...
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has announced a research partnershi...
Scientists from A*STAR Infectious Diseases Labs (A*STAR IDL), Nanyang Technological University, Singapore’s Lee Ko...
When the liver fails, toxins – such as ammonia – that should be filtered from the blood build up and reach t...
Japan-based iPark Institute has signed a Memorandum of Understanding (MoU) with Taiwan’s Industrial Technology Res...
Researchers at King Abdullah University of Science and Technology (KAUST), Saudi Arabia, have developed a new method to ...
Taiwan-based China Medical University Hospital (CMUH), in collaboration with Ever Supreme International Biotechnology an...
NTU Singapore and Nanofilm Technologies International (NTI Nanofilm) have officially opened the NTI-...
Mirxes, the only publicly-listed molecular cancer early detection company in Asia Pacific, has developed an AI assistant...
Israel-based Galmed Pharmaceuticals, a clinical-stage biopharmaceutical company for liver disease and GI oncological the...
The Center for Myokine Convergence Research at Korea University College of Medicine has signed a memorandum of understan...
Chulalongkorn University, in collaboration with the Thai Red Cross Society and Specialty Innovation Co., ...
Belief BioMed and Grand Life Sciences have signed an exclusive collaboration to commercialize BBM-H803 for hemophilia ...
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) Antimicrobial Resistance (AMR) group, in...
Precision oncology firm, Lucence, with Diagnostics Development Hub (DxD Hub), hosted by the Agency for Science, Techno...
Researchers at Singapore's NUS Medicine have developed a method to enhance compact gene-editing tools called base editor...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
